Acquiring Maternal Immunoglobulin Different Receptors, Similar Functions by Ward, E.Sally
Immunity, Vol. 20, 507–508, May, 2004, Copyright 2004 by Cell Press
Preview
can accommodate the known functions for FcRn, andAcquiring Maternal
in vitro studies provide support for its validity.Immunoglobulin: Different In birds and some reptiles, maternal immunoglobulin
Y (IgY) is transported into the egg yolk prior to transferReceptors, Similar Functions
at a late stage of embryonic development into the em-
bryonic bloodstream. IgY has CH2, CH3, and CH4 domains
and is believed to be the evolutionary precursor of IgG
and IgE (the CH3 and CH4 domains of IgY resemble the
The isolation of a novel Fc receptor (FcRY) from CH2 and CH3 domains of IgG, respectively) (Warr et al.,
chicken yolk sac provides insight at the mechanistic 1995). IgY transport into the embryo is specific and bind-
level as to how avian maternal immunoglobulin (IgY) ing of IgY to the yolk sac membrane is much greater at
is transferred to offspring. This receptor is distinct pH 6 than at pH 7.4. Given that the pH of yolk is 6, it
from its mammalian counterpart and is a phospholi- therefore might be predicted that transport of IgY from
pase A2 receptor homolog. Biophysical analyses indi- yolk to the embryonic circulation resembles the FcRn-
cate that FcRY achieves pH-dependent binding to IgY mediated delivery of IgG across the rodent neonatal
through a conformational change. intestine. On the other hand, FcRn does not bind to
IgY and mammalian IgGs do not transfer into the chick
embryo (Brambell, 1970), suggesting that a distinct re-The transport of maternal immunoglobulin (Ig) to off-
ceptor might be involved in IgY transport. Therefore, anspring plays a pivotal role in conferring humoral immu-
important question concerns the nature of the receptornity during the early stages of life. In mammals, delivery
responsible for IgY transport from yolk to embryo. In aof maternal immunoglobulin G (IgG) is known to involve
report from the Bjorkman lab (West et al., 2004, thisthe MHC class I related receptor, FcRn (n  neonatal;
issue of Immunity), an Fc receptor with the requisitereviewed in Ghetie and Ward, 2000). IgG transfer can
properties for IgY transport has been isolated and char-occur at both the pre- and postnatal stages, with the
acterized. The approach taken was to purify an Fc re-proportion of transport at each stage varying across
ceptor from chicken yolk sac, using the property ofspecies (Brambell, 1970). Prenatal delivery occurs
pH-dependent binding to IgY as a tool for isolation.across the placental or yolk sac barrier, whereas post-
Interestingly, this receptor (called FcRY) bears no simi-natal transfer involves passage from mother’s milk/co-
larity to FcRn but is a homolog of the mammalian secre-lostrum across the neonatal intestine. FcRn orthologs
tory phospholipase A2 receptor (PLA2R). As for PLA2R,have been isolated from multiple mammalian species,
FcRY is a type I membrane protein for which the ectodo-suggesting that the mechanisms of maternal IgG deliv-
main comprises an N-terminal cysteine-rich (CysR) do-ery are similar across mammalia.
main, a fibronectin type II (FNII) domain, and eight C-type
Over the past decade, multiple studies have demon-
lectin-like domains (CTLDs, a misleading classification
strated that in addition to its role in transporting maternal
as most of these domains do not have C-type lectin
IgG, FcRn regulates IgG levels throughout life at diverse activity). This Fc receptor therefore falls into the hetero-
sites in the body (Ghetie and Ward, 2000). For example, geneous mannose receptor (MR) family of proteins.
FcRn controls the serum half-lives of IgG molecules Binding studies with soluble, recombinant FcRY frag-
by salvaging them from lysosomal degradation. As a ments demonstrate that the interaction site for IgY can
consequence, the affinity of an IgG for FcRn provides be reconstituted by mixing recombinant CysR-FNII do-
a good predictor of its serum persistence. FcRn is also mains with the eight CTLDs, whereas the smaller sub-
involved in transporting IgG across cellular barriers such fragments that are tested do not have binding activity
as lung epithelia (Spiekermann et al., 2002). The function (West et al., 2004). The binding site for FcRY on IgY is
of FcRn, which was originally believed to act solely dur- currently not mapped, although an FcY fragment com-
ing the prenatal/neonatal periods, has therefore re- prising both CH3 and CH4 domains binds with properties
quired redefinition to encompasss a broader role in similar to those of IgY. Despite the presence of CTLDs
IgG transport. and a CysR domain, which for the MR have carbohydrate
A characteristic feature of FcRn is that it binds to IgG binding activity (East and Isacke, 2002), the data pre-
in a pH-dependent way, with relatively tight binding at sented indicate that IgY carbohydrate is unlikely to be
pH 6 that becomes progressively weaker as neutral pH involved in the IgY-FcRY interaction. An inability to bind
is approached (Ghetie and Ward, 2000). This pH depen- carbohydrate is a feature of the majority of CysR do-
dence is essential for FcRn function and has resulted mains and CTLDs of MR family members (East and
in models where, following uptake by fluid phase pino- Isacke, 2002), indicating that FcRY is not an outlier in
cytosis, IgG interacts with FcRn in acidic early endo- this respect.
somes. IgG bound to FcRn is sorted into the recycling A significant observation of the study of West et al.
or transcytotic pathway, whereas unbound IgG enters (2004) is that the mechanism by which pH-dependent
the lysosomal route (Ober et al., 2004). A minor variation binding by FcRY to IgY is achieved is distinct to that
of this model is that for cells such as neonatal intestinal employed by FcRn. IgG-FcRn interactions involve sev-
cells that are bathed in a slightly acidic milieu, IgG can eral key histidine residues located at the CH2-CH3 do-
main interface of IgG that interact with acidic FcRn resi-bind to cell surface FcRn. In general terms, this model
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dues (Martin et al., 2001; Medesan et al., 1997). pH should be possible to address by biochemical and high-
resolution structural studies. There are also issues atdependence for FcRn binding to IgG therefore entails a
chemical change, involving deprotonation/protonation the cellular level that are of considerable interest. For
example, how does this receptor traffic intracellularly,cycles rather than a conformational alteration. In con-
trast, a combination of surface plasmon resonance and and does it play a more general role in regulating IgY
levels throughout life? The properties of FcRY add tosedimentation analyses indicate that a conformational
change mediates the pH dependence of the IgY-FcRY the diversity of functions that are exhibited by previously
characterized members of the MR family (East andinteraction (West et al., 2004). A model is proposed in
which the CysR-FNII domains fold back onto the CTLDs Isacke, 2002). Finally, but not least important, the study
of West et al. (2004) has consequences at the evolution-at pH 6 to form an IgY interaction site. By analogy,
the CysR domain of the MR family member, Endo180, ary level insofar as it suggests that the role of MHC
class I molecules in antigen presentation evolved priorappears to contact the second CTLD in a mode that
may resemble the “folded back” conformation of FcRY. to their ability to bind IgG.
At pH 8.0 the CysR-FNII domains of FcRY no longer
interact with the CTLDs and the receptor forms a more E. Sally Ward
extended conformation in which the IgY interaction site Center for Immunology
is lost. UT Southwestern Medical Center
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